- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.04. | BeiGene abandons TIGIT antibody after lung cancer flop | ||
| 03.04. | Multiple studies of Sarepta's DMD therapy halted after death | ||
| 03.04. | Germany will reimburse haemophilia gene therapy Hemgenix | ||
| 03.04. | Novartis gets FDA nod for second of three IgAN drugs | ||
| 03.04. | Pharma in a spin as it tries to gauge Trump tariffs impact | ||
| 02.04. | First drug backed for NHS use in untreated Hodgkin lymphoma | ||
| 02.04. | Third time not so lucky in J&J's bid to end talc liability | ||
| 02.04. | Study links 'bad cholesterol' to dementia | ||
| 02.04. | Pharma tariffs "will hurt US consumers most of all" | ||
| 02.04. | Death penalty sought for suspect in UnitedHealth CEO killing | ||
| 01.04. | RIF job losses are underway at HHS agencies; reports | ||
| 01.04. | UK first to approve Rotop's prostate cancer imaging agent | ||
| 01.04. | EVERSANA joins with Veeva in push to 'pharmatise AI' | ||
| 01.04. | ACC25: AZ stakes its claim to the oral PCSK9 category | ||
| 01.04. | ACC25: Mineralys' uncontrolled hypertension drug aces trial | ||
| 31.03. | Alphabet's Isomorphic raises $600m for AI drug discovery | ||
| 31.03. | ACC25: Ozempic shows its value in PAD | ||
| 31.03. | ACC25: Positive results with Lilly's Lp(a)-lowering drug | ||
| 31.03. | Industry alarm as FDA's CBER head Peter Marks resigns | ||
| 31.03. | Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla | ||
| 28.03. | MSD says subcutaneous Keytruda matches IV form | ||
| 28.03. | Lilly adds Alzheimer's to its DTC platform LillyDirect | ||
| 28.03. | Chiesi backs growth plans with a €430m new plant in Italy | ||
| 27.03. | First gene-edited pig liver transplant 'worked for 10 days' | ||
| 27.03. | HHS plans 10,000 more job cuts, taking target to 20,000 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
